CLPTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

ClearPoint Neuro, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026

$9.17+0.10 (+1.10%)

Close on Oct 19, 2026

Market cap: $276.63M
P/E (TTM): –
Dividend yield: –

ClearPoint Neuro, Inc. balance sheet

Annual Quarterly

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31	FY 2009 2009-12-31
Cash & Equivalents	46	20	23	28	54	20	5.70	3.10	9.29	3.32	5.41	9.24	3.52	1.62	0.15	1.58	2.57
Short-Term Investments	–	–	0	9.87	0	–	–	–	–	–	–	–	–	–	–	–	–
Cash & Short-Term Investments	46	20	23	37	54	20	5.70	3.10	9.29	3.32	5.41	9.24	3.52	1.62	0.15	1.58	2.57
Receivables	6.55	4.71	3.21	2.67	2.34	1.88	1.09	1.23	0.95	0.87	1.22	0.47	0.77	0.45	0.40	–	–
Inventory	8.36	6.86	7.91	9.30	4.94	3.24	3.24	2.11	2.31	1.77	1.81	1.97	1.48	0.90	0.97	–	–
Prepaid Expenses & Other	2.77	1.68	1.91	1.72	0.51	0.24	0.36	0.21	0.19	0.13	0.10	0.03	0.17	0.11	0.02	–	–
Total Current Assets	64	33	36	51	62	25	10	6.65	13	6.09	8.53	12	5.94	3.08	1.54	–	–
Property, Plant & Equipment	2.62	2.01	1.39	0.81	0.54	0.32	0.45	0.38	0.27	0.33	0.44	0.48	0.90	1.29	1.22	–	–
Gross Property, Plant & Equipment	4.34	3.35	2.33	2.58	2.43	2.14	2.24	2.10	1.94	2.04	2.17	2.23	2.40	2.49	2.02	–	–
Accumulated Depreciation	-1.72	-1.34	-0.95	-1.77	-1.89	-1.82	-1.79	-1.72	-1.67	-1.71	-1.73	-1.74	-1.50	-1.20	-0.80	–	–
Operating Lease Right-of-Use Assets	8.43	3.09	3.56	1.90	2.24	2.74	0.37	–	–	–	–	–	–	–	–	–	–
Goodwill	7.47	7.47	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Intangible Assets	14	0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Other Long-Term Assets	1.70	0.74	0.11	0.13	0.13	0.06	0.22	0.02	0.01	0.01	0.03	0.29	0.10	0.05	0.06	–	–
Total Assets	98	39	43	55	66	30	12	7.86	14	7.40	9.94	13	7.87	5.55	3.03	–	–
Accounts Payable	1.26	1.34	0.39	0.27	0.43	0.30	0.97	0.50	0.76	1.55	0.70	1.00	1.38	1.96	4.04	–	–
Current Portion of Leases	0.69	0.56	0.42	0.56	0.51	0.39	0.11	–	–	–	–	–	–	–	–	–	–
Deferred Revenue (Current)	1.67	2.12	2.61	1.07	0.68	0.56	1.02	0.21	0.26	0.22	0.12	0.10	0.11	0.11	–	–	–
Other Current Liabilities	–	–	–	–	–	–	–	–	–	–	–	–	–	4.18	–	–	–
Total Current Liabilities	11	10	7.43	6.79	4.75	3.20	3.83	1.87	4.40	3.02	7.65	4.92	10	6.31	15	–	–
Long-Term Debt	49	0	–	–	–	–	–	–	–	–	–	4.02	3.85	2.00	–	–	–
Long-Term Leases	8.46	3.01	3.57	1.53	1.94	2.45	0.28	–	–	–	–	–	–	–	–	–	–
Operating Lease Liabilities	9.16	3.57	3.99	2.09	2.45	2.96	0.39	–	–	–	–	–	–	–	–	–	–
Deferred Tax Liabilities	0.35	0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Other Long-Term Liabilities	0.49	0	–	–	–	–	–	–	–	–	–	–	–	7.11	–	–	–
Total Liabilities	70	14	21	19	17	27	7.34	6.35	8.07	8.16	12	13	15	13	25	–	–
Total Debt	49	0	–	–	–	–	–	–	–	–	–	4.02	3.85	2.00	–	–	–
Preferred Stock	0	0	0	0	0	0	–	–	–	–	–	–	–	–	7.97	–	–
Common Stock	0.29	0.28	0.25	0.25	0.24	0.17	0.15	0.11	0.11	0.04	0.02	0.75	0.59	0.48	0.16	–	–
Additional Paid-In Capital	239	216	193	187	182	122	117	109	107	93	84	76	65	59	31	–	–
Retained Earnings	-217	-191	-172	-150	-134	-120	-113	-107	-101	-94	-86	-77	-73	-66	-60	–	–
Treasury Stock	–	–	–	–	–	–	–	–	–	–	–	–	–	-1.68	-1.68	–	–
Shareholders' Equity	28	25	21	37	49	2.38	4.59	1.51	5.83	-0.76	-1.98	-0.10	-6.83	-7.87	-22	-15	-9.89
Total Equity	28	25	21	37	49	2.38	4.59	1.51	5.83	-0.76	-1.98	-0.10	-6.83	-7.87	-22	-15	-9.89
Total Liabilities & Equity	98	39	43	55	66	30	12	7.86	14	7.40	9.94	13	7.87	5.55	3.03	–	–
Shares Outstanding(shares)	29	28	25	25	24	17	15	11	11	3.62	2.28	1.87	1.46	1.20	0.40	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 62.6%
Operating margin: -73.4%
Net margin: -81.8%
Return on equity, FY2025: -95.6%

Financial strength

Current ratio: 4.74
Debt to equity: 4.66
Debt to assets: 57.9%
Cash to current liabilities: 284.7%

Valuation

P/E ratio: –
Price to sales: 6.54
Price to book: 25.67
Dividend yield: –